Garry Ashton

1.7k total citations
22 papers, 773 citations indexed

About

Garry Ashton is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Garry Ashton has authored 22 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Garry Ashton's work include Immunotherapy and Immune Responses (4 papers), MRI in cancer diagnosis (2 papers) and CAR-T cell therapy research (2 papers). Garry Ashton is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), MRI in cancer diagnosis (2 papers) and CAR-T cell therapy research (2 papers). Garry Ashton collaborates with scholars based in United Kingdom, United States and Germany. Garry Ashton's co-authors include Wolfgang Breitwieser, Georges Lacaud, Valérie Kouskoff, David E. Gilham, Dominic G. Rothwell, Eleanor J. Cheadle, Nic Jones, Robert E. Hawkins, Ann M. Flenniken and M.A. Willington and has published in prestigious journals such as Genes & Development, Blood and The Journal of Immunology.

In The Last Decade

Garry Ashton

22 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garry Ashton United Kingdom 15 303 217 162 117 98 22 773
M. Gorre United States 15 443 1.5× 286 1.3× 141 0.9× 159 1.4× 94 1.0× 28 1.3k
Stacey A. Snyder United States 12 202 0.7× 177 0.8× 253 1.6× 64 0.5× 86 0.9× 16 776
Jonathan V. Nguyen United States 10 335 1.1× 167 0.8× 103 0.6× 97 0.8× 77 0.8× 35 610
Mohammad Azam United States 18 694 2.3× 318 1.5× 116 0.7× 99 0.8× 77 0.8× 36 1.6k
Keren Levanon Israel 18 534 1.8× 329 1.5× 313 1.9× 169 1.4× 216 2.2× 31 1.3k
Arvind Rao United States 12 375 1.2× 159 0.7× 157 1.0× 298 2.5× 34 0.3× 27 815
Roger Luo United States 16 694 2.3× 130 0.6× 147 0.9× 220 1.9× 78 0.8× 30 1.3k
Enken Drecoll Germany 22 385 1.3× 423 1.9× 172 1.1× 98 0.8× 39 0.4× 36 1.1k
Stephanie M. McGregor United States 18 490 1.6× 345 1.6× 245 1.5× 148 1.3× 66 0.7× 52 1.3k
Bart A. Westerman Netherlands 21 769 2.5× 225 1.0× 182 1.1× 110 0.9× 31 0.3× 52 1.3k

Countries citing papers authored by Garry Ashton

Since Specialization
Citations

This map shows the geographic impact of Garry Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Ashton more than expected).

Fields of papers citing papers by Garry Ashton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Ashton. The network helps show where Garry Ashton may publish in the future.

Co-authorship network of co-authors of Garry Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Ashton. A scholar is included among the top collaborators of Garry Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Ashton. Garry Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashton, Garry, et al.. (2024). Integrating Spatial and Morphological Characteristics into Melanoma Prognosis: A Computational Approach. Cancers. 16(11). 2026–2026. 2 indexed citations
2.
Mével, Renaud, Amin Ali, Pengbo Wang, et al.. (2023). Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells. Cell Reports. 42(4). 112377–112377. 4 indexed citations
3.
MacKintosh, Michelle L., Rhona J. McVey, James M. Bolton, et al.. (2021). The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium. International Journal of Obesity. 46(3). 605–612. 34 indexed citations
4.
Lee, Rebecca, Garima Khandelwal, Franziska Baenke, et al.. (2020). Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma. ESMO Open. 5(4). e000707–e000707. 3 indexed citations
5.
Salem, Ahmed, Ross A. Little, Ayşe Latif, et al.. (2019). Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non–small Cell Lung Cancer. Clinical Cancer Research. 25(13). 3818–3829. 61 indexed citations
6.
Fergie, Martin, Catharine West, Kim Linton, et al.. (2018). Quantifying cell-type interactions and their spatial patterns as prognostic biomarkers in follicular lymphoma. Research Explorer (The University of Manchester). 22. 15–15. 2 indexed citations
7.
8.
Little, Ross A., Yann Jamin, Jessica K.R. Boult, et al.. (2018). Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology. Radiology. 288(3). 739–747. 38 indexed citations
9.
Barros‐Silva, João D., Douglas E. Linn, Guoji Guo, et al.. (2018). Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Reports. 25(12). 3504–3518.e6. 64 indexed citations
10.
Lamarca, Ángela, Daisuke Nonaka, Wolfgang Breitwieser, et al.. (2018). PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours. Oncotarget. 9(19). 14922–14938. 33 indexed citations
11.
Diamantopoulou, Zoi, Gavin White, Muhammad Zaki Hidayatullah Fadlullah, et al.. (2017). TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells. Cancer Cell. 31(5). 621–634.e6. 75 indexed citations
12.
Ashton, Garry, Domenico Coppola, Yvonne De Souza, et al.. (2016). A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience. Biopreservation and Biobanking. 14(5). 429–439. 20 indexed citations
13.
Galvani, Elena, Kate Hogan, Gabriela Gremel, et al.. (2016). Abstract 3207: Influence of tumor mutation burden on response to anti-PD-1 treatment in murine models of melanoma. Cancer Research. 76(14_Supplement). 3207–3207. 2 indexed citations
14.
Karimiani, Ehsan Ghayoor, Garry Ashton, Lia P. Menasce, et al.. (2013). PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome. Journal of Clinical Pathology. 66(9). 764–767. 14 indexed citations
15.
Ackermann, Julien, Garry Ashton, Dominic I. James, et al.. (2011). Loss of ATF2 Function Leads to Cranial Motoneuron Degeneration during Embryonic Mouse Development. PLoS ONE. 6(4). e19090–e19090. 27 indexed citations
16.
Holland, Mark, Fernanda Castro, Duncan L. Smith, et al.. (2011). RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia. Blood. 118(3). 638–649. 42 indexed citations
17.
Betsou, Fay, Sylvain Lehmann, Garry Ashton, et al.. (2010). Standard Preanalytical Coding for Biospecimens: Defining the Sample PREanalytical Code. Cancer Epidemiology Biomarkers & Prevention. 19(4). 1004–1011. 131 indexed citations
18.
19.
Breitwieser, Wolfgang, Ann M. Flenniken, Garry Ashton, et al.. (2007). Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes & Development. 21(16). 2069–2082. 91 indexed citations
20.
Cheadle, Eleanor J., Daren Subar, Dominic G. Rothwell, et al.. (2007). Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy. Clinical Cancer Research. 13(19). 5719–5728. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Gorre Breakdown of academic impact, for papers by Stacey A. Snyder Breakdown of academic impact, for papers by Jonathan V. Nguyen Breakdown of academic impact, for papers by Mohammad Azam Breakdown of academic impact, for papers by Keren Levanon Breakdown of academic impact, for papers by Arvind Rao Breakdown of academic impact, for papers by Roger Luo Breakdown of academic impact, for papers by Enken Drecoll Breakdown of academic impact, for papers by Stephanie M. McGregor Breakdown of academic impact, for papers by Bart A. Westerman
Rankless by CCL
2026